Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma — Stella

Recruiting

Back to Nasopharyngeal Carcinoma (NPC) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan

Key details

Sponsor

The Second Affiliated Hospital of Hainan Medical University

Enrollment target

~24 participants

Started

February 2026

Primary completion

December 2026

Age range

18 Years – 75 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov